Journal Home
Search for

Volume 9, Issue 3, Pages 208-212 (July 2010)


View previous. 10 of 24 View next.

Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy

Fabio L. Cury1Corresponding Author Informationemail address, Marie Duclos1, Armen Aprikian2, Horacio Patrocinio3, Luis Souhami1

Received 18 June 2009; received in revised form 24 August 2009; accepted 24 September 2009. published online 10 February 2010.

Abstract 

Purpose

High–dose rate brachytherapy (HDRB) is frequently used as a boost to external beam radiation therapy (EBRT) in prostate cancer patients. With the increasing use of small planning target volume margins in EBRT, prostatic edema induced by HDRB can be a contributing factor to geometric miss when HDRB is performed before or during EBRT. We assessed prostate gland volumetric change after single-fraction HDRB and its impact on definition of treatment volume for EBRT.

Methods and Materials

Thirty-one consecutive patients with intermediate-risk prostate cancer treated with single-fraction HDRB (10Gy) combined with hypofractionated EBRT were analyzed. A second CT scan was performed 7 days after HDRB, and images were coregistered with the planning CT scan that contained the original clinical target volume (CTV). The post-HDRB prostate CTV volume was compared with the original CTV by a single observer.

Results

All patients presented volumetric variation. In most cases (68%), the prostate increased in volume, whereas it decreased in 32%. The mean prostatic volume was 42.2cc before HDRB and 43.6cc after HDRB, representing a mean volume difference of 3.4%, ranging from −14.2% to 23.8% (p=0.756). This difference is the result of mean changes of 0.6mm (−6.1 to 6.6) in the anterior–posterior, 0.5mm (−5.5 to 3.0) in the lateral, and 0.2mm (−5.0 to 5.0) in the superior–inferior axes.

Conclusions

Although a nonsignificant volumetric change occurs after single-fraction HDRB, individual variations on specific axis could lead to important uncertainties during EBRT.

1 Division of Radiation Oncology, Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada

2 Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada

3 Department of Medical Physics, McGill University Health Centre, Montreal, Quebec, Canada

Corresponding Author InformationCorresponding author. Montreal General Hospital, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec H3G 1A4, Canada. Tel.: +1-514-934-8040; fax: +1-514-934-8220.

PII: S1538-4721(09)00358-4

doi:10.1016/j.brachy.2009.09.003


View previous. 10 of 24 View next.